SEC Filings

SEC Filings

Other Filings
Filing Description Filing Type Filing Date Event Date  
8-K 8-K 8/31/2018 8/30/2018
Abstract: 8-K filed by Diffusion Pharmaceuticals Inc. (DFFN) covering Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing.
8-K 8-K 8/14/2018 8/13/2018
Abstract: 8-K filed by Diffusion Pharmaceuticals Inc. (DFFN) covering Results of Operations and Financial Condition; Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year; and Financial Statements and Exhibits.
10-Q 10-Q 8/10/2018 6/30/2018
Registration Statement S-8 8/10/2018
8-K 8-K 6/15/2018 6/14/2018
Abstract: 8-K filed by Diffusion Pharmaceuticals Inc. (DFFN) covering Submission of Matters to a Vote of Security Holder.
8-K 8-K 5/10/2018 5/10/2018
Abstract: 8-K filed by Diffusion Pharmaceuticals Inc. (DFFN) covering Results of Operations and Financial Condition and Financial Statements and Exhibits.
10-Q 10-Q 5/10/2018 3/31/2018
Proxy DEF 14A 4/30/2018 6/14/2018
Proxy DEFA14A 4/30/2018
Proxy PRE 14A 4/20/2018 6/14/2018
8-K 8-K 4/3/2018 4/3/2018
Abstract: 8-K filed by Diffusion Pharmaceuticals Inc. (DFFN) covering Results of Operations and Financial Condition and Financial Statements and Exhibits.
10-K 10-K 4/2/2018 12/31/2017
8-K 8-K 3/19/2018 3/13/2018
Abstract: 8-K filed by Diffusion Pharmaceuticals Inc. (DFFN) covering Departure of Directors or Principal Officers; Election of Directors; Appointment of Principal Officers.
8-K 8-K 3/5/2018 3/2/2018
Abstract: 8-K filed by Diffusion Pharmaceuticals Inc. (DFFN) covering Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing.
Prospectus 424B3 2/14/2018
Registration Statement S-3 2/6/2018
13-D SC 13G/A 1/29/2018
8-K 8-K 1/22/2018 1/22/2018
Abstract: 8-K filed by Diffusion Pharmaceuticals Inc. (DFFN) covering Other Events and Financial Statements and Exhibits.
8-K 8-K 1/19/2018 1/18/2018
Abstract: 8-K filed by Diffusion Pharmaceuticals Inc. (DFFN) covering Entry into a Material Definitive Agreement; Other Events; and Financial Statements and Exhibits.
Prospectus 424B4 1/19/2018

Displaying 1 to 20 (of 162 filings)